Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

NCT00389506 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: LMB-2 immunotoxin
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
OTHER: pharmacological study

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]